Drug company Eli Lilly will close factory in Brazil

U.s. pharmaceutical Eli Lilly reported that will close your factory in Brazil, located in the Morumbi, in São Paulo. The unit is responsible for the production of solid drugs, such as tablets and capsules. The order of operations will occur within three years. The closure of the unit, according to the company, due to the need to "balance the production capacity of the company with the needs of your portfolio". According to Eli Lilly, the brazilian unit's operations will be transferred to Puerto Rico, as well as those of Spain. Despite closing the brazilian factory, Eli Lilly argues that the country is an important market for the company. "In 2018, Lilly held six releases in the country, with a growth of 22% compared to 2017" in note.